4//SEC Filing
Ferguson Merle 4
Accession 0001091818-23-000178
CIK 0001310488other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:07 PM ET
Size
5.0 KB
Accession
0001091818-23-000178
Insider Transaction Report
Form 4
Ferguson Merle
DirectorCEO/President/Treasurer10% Owner
Transactions
- Gift
Common Stock
2023-05-12−500,000→ 16,470,000 total(indirect: Shares Held in Private Company)
Footnotes (1)
- [F1]15,000,000 share are held directly by the reporting individual, 1,470,000 shares held indirectly in a business entity that the reporting person is an executive officer. Total direct and indirect beneficial ownership is 16,470,000.
Documents
Issuer
BIOFORCE NANOSCIENCES HOLDINGS, INC.
CIK 0001310488
Entity typeother
Related Parties
1- filerCIK 0001749860
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 4:07 PM ET
- Size
- 5.0 KB